Copy number variation of the APC gene is associated with regulation of bone mineral density☆

[1]  T. Spector,et al.  Homozygous deletion of the UGT2B17 gene is not associated with osteoporosis risk in elderly Caucasian women , 2011, Osteoporosis International.

[2]  J. Wit,et al.  APC mutations are associated with increased bone mineral density in patients with familial adenomatous polyposis , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  F. Deng,et al.  Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians , 2010, Osteoporosis International.

[4]  J. Kanis,et al.  DIAGNOSIS OF OSTEOPOROSIS , 2016 .

[5]  K. Roeder,et al.  High‐Density Association Study of 383 Candidate Genes for Volumetric BMD at the Femoral Neck and Lumbar Spine Among Older Men , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Yurii S. Aulchenko,et al.  Twenty bone mineral density loci identified by large-scale meta-analysis of genome-wide association studies , 2009, Nature Genetics.

[7]  K. Ozono,et al.  Wnt signaling in bone metabolism , 2009, Journal of Bone and Mineral Metabolism.

[8]  Yan Guo,et al.  Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. , 2008, American journal of human genetics.

[9]  A Hofman,et al.  Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study , 2008, The Lancet.

[10]  A. Singleton,et al.  Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia , 2008, Science.

[11]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[12]  S. Steer,et al.  Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[13]  Bi Zhou,et al.  Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. , 2007, American journal of human genetics.

[14]  R. Baron,et al.  Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. , 2007, Endocrinology.

[15]  Philippe Froguel,et al.  FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity , 2007, Nature Genetics.

[16]  Kenny Q. Ye,et al.  Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.

[17]  O. MacDougald,et al.  Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.

[18]  W. Honer,et al.  DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. , 2006, Human molecular genetics.

[19]  Bart O. Williams,et al.  Essential Role of β-Catenin in Postnatal Bone Acquisition* , 2005, Journal of Biological Chemistry.

[20]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[21]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[22]  L. Christiansen,et al.  Possible gene dosage effect of glutathione‐S‐transferases on atopic asthma: Using real‐time PCR for quantification of GSTM1 and GSTT1 gene copy numbers , 2004, Human mutation.

[23]  Gary S Stein,et al.  The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. , 2004, Molecular endocrinology.

[24]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[25]  Ivan Lobov,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[26]  V. Bubb,et al.  Adenomatous polyposis coli (APC), β‐catenin, and cadherin are expressed in human bone and cartilage , 2001, Histopathology.

[27]  H. Clevers,et al.  Mutations in the APC tumour suppressor gene cause chromosomal instability , 2001, Nature Cell Biology.

[28]  H. Clevers,et al.  Linking Colorectal Cancer to Wnt Signaling , 2000, Cell.

[29]  Michele Pagano,et al.  Wnt/β-Catenin Signaling Induces the Expression and Activity of βTrCP Ubiquitin Ligase Receptor , 2000 .

[30]  Paul Polakis,et al.  The oncogenic activation of β-catenin , 1999 .

[31]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[32]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[33]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[34]  C. L. Adams,et al.  The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration , 1996, The Journal of cell biology.

[35]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[36]  J. Stockman.  Association between Microdeletion and Microduplication at 16p11.2 and Autism , 2009 .

[37]  M. Bouxsein,et al.  Essential role of beta-catenin in postnatal bone acquisition. , 2005, The Journal of biological chemistry.

[38]  V. Baranov,et al.  Glutathione-S-transferase µ and theta gene polymorphisms as new risk factors of atopic bronchial asthma , 2002, Journal of Molecular Medicine.

[39]  T. Spector,et al.  Genetic Variation in Bone Mineral Density and Calcaneal Ultrasound: A Study of the Influence of Menopause Using Female Twins , 2001, Osteoporosis International.

[40]  T. Slaga,et al.  Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor. , 2000, Molecular cell.

[41]  P. Polakis.  The oncogenic activation of beta-catenin. , 1999, Current opinion in genetics & development.

[42]  A. Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. , 1998, The EMBO journal.

[43]  Thierry Soussi,et al.  APC gene: database of germline and somatic mutations in human tumors and cell lines , 1996, Nucleic Acids Res..